SCHEMBL18914541

SCHEMBL18914541

Cc1ccc(CO)c(N2CCOCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
PRKDC P78527 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
AKR1C3 P42330 1/20 0.46
P2RX7 Q99572 1/20 0.46
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 1/20 0.45
CYP3A4 P08684 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
MAPT P10636 3/20 0.43
CYP2D6 P10635 1/20 0.43
NCF1 P14598 1/20 0.42
GAA P10253 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
CYP1A2 P05177 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15831849 0.84 PRKDC (0.47) ALDH1A1PRKDCL3MBTL1P2RX7LMNA
SCHEMBL5337316 0.81 HTR1A (0.51) CYP3A4CYP2C9CYP2D6CYP1A2
SCHEMBL5793530 0.79 NCF1 (0.45) ALDH1A1PRKDCLMNASMN1; SMN2HPGD
SCHEMBL19212319 0.78 MAPT (0.53) ALDH1A1PRKDCL3MBTL1AKR1C3P2RX7
SCHEMBL3885064 0.78 KMT2A (0.53) ALDH1A1PRKDCL3MBTL1LMNASMN1; SMN2
SCHEMBL16577085 0.77 HTR1A (0.45) PRKDCP2RX7LMNACYP2C9CYP1A2
SCHEMBL1715455 0.76 AKR1C3 (0.50) ALDH1A1PRKDCL3MBTL1AKR1C3P2RX7
SCHEMBL12864867 0.76 MAPT (0.64) ALDH1A1PRKDCL3MBTL1AKR1C3P2RX7
SCHEMBL23168991 0.76 PRKDC (0.43) ALDH1A1PRKDCL3MBTL1P2RX7LMNA
SCHEMBL18914549 0.76 PRKDC (0.43) ALDH1A1PRKDCL3MBTL1P2RX7LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3381913-B1 2-(((PYRROLIDIN-3-YL)CARBONYL)AMINO)-1H-IMIDAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR 1 (MCR1) AGONISTS FOR TREATING RHEUMATOID ARTHRITIS MITSUBISHI TANABE PHARMA CORP (JP) 2021-03-31 EP disclosed
WO-2017090743-A1 NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST 田辺三菱製薬株式会社 2017-06-01 WO disclosed